India on Friday took a step closer to licensing a vaccine against Covid-19 as an expert panel appointed by the government recommended that the apex drug regulator grant emergency use authorisation to the Oxford-AstraZeneca vaccine. The approval by the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) paves the way for mass immunisation with the vaccine to begin within the next few days. The government wants to start administering the vaccine soon, most likely by Wednesday, news agency Reuters reported, quoting an unnamed official source. An official announcement is expected later in the day.
#Covishield #OxfordAstraZeneca #Coronavirus #Vaccine
Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
